Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis by Huy, Nguyen T et al.
RESEARCH Open Access
Cerebrospinal fluid lactate concentration to
distinguish bacterial from aseptic meningitis:
a systemic review and meta-analysis
Nguyen T Huy
1, Nguyen TH Thao
2, Doan TN Diep
2,3, Mihoko Kikuchi
1,4, Javier Zamora
5, Kenji Hirayama
1,4,6*
Abstract
Introduction: Making a differential diagnosis between bacterial meningitis and aseptic meningitis is a critical clinical
problem. The utility of a cerebrospinal fluid (CSF) lactate assay for this purpose has been debated and is not yet
routinely clinically performed. To adequately evaluate this assay, a systematic review and meta-analysis of studies of
the CSF lactate concentration as a marker for both bacterial meningitis and aseptic meningitis was performed.
Methods: Electronic searches in PubMed, Scopus, the MEDION database and the Cochrane Library were conducted
to identify relevant articles published before March 2009. A manual search of reference lists from selected articles
was also conducted. Two reviewers independently selected relevant articles and extracted data on study
characteristics, quality and accuracy.
Results: Twenty-five articles were identified that met the eligibility criteria. Diagnostic odds ratios were
considerably homogenous (Chi-square P = 0.1009, I
2 = 27.6%), and the homogeneity was further confirmed by a
Galbraith plot and meta-regression analysis using several covariates. The symmetrical summary receiver-operator
characteristic curve (SROC), fitted using the Moses-Shapiro-Littenberg method, was positioned near the upper left
corner of the SROC curve. The Q value and area under the curve were 0.9451 and 0.9840, respectively, indicating
excellent accuracy. The diagnostic accuracy of the CSF lactate concentration was higher than those of other four
conventional markers (CSF glucose, CSF/plasma glucose quotient, CSF protein, and CSF total number of leukocytes)
using a head to head meta-analysis of the 25 included studies.
Conclusions: To distinguish bacterial meningitis from aseptic meningitis, CSF lactate is a good single indicator and
a better marker compared to other conventional markers.
Introduction
Accurate and rapid diagnosis of acute bacterial meningi-
tis (BM) is essential because disease outcome depends on
immediate initiation of appropriate antibiotic therapy [1].
BM should be treated promptly with antibiotics, whereas
acute aseptic meningitis (AM) is usually self limiting.
However, differentiating BM from AM may be challen-
ging for clinicians because the symptoms and laboratory
assays are often similar and overlapping. In addition, clas-
sical clinical manifestations of BM in infants and children
are usually difficult to recognize because of the absence
of signs of meningeal irritation and because of delayed
elevation of intracranial pressure. Parameters examined
in cerebrospinal fluid (CSF) are less descriptive in chil-
dren than in adults: in enterovirus meningitis, CSF para-
meters can be practically identical to those of bacterial
meningitis. For example, acute meningitis with predomi-
nance of neutrophils in CSF suggests BM; however,
herpes simplex-1 infected meningitis presents with > 90%
neutrophils in CSF [2]. Furthermore, other assays, such
as Gram stain, latex agglutination, and polymerase chain
reaction-based assays, lack sensitivity [3-6]. In practice,
before definitive CSF bacterial cultures are available, most
patients with acute meningitis are treated with broad-
spectrum antibiotics targeting BM. In general, this does
not seriously harm the AM patient; however, it may
enhance the local frequency of antibiotic resistance [7]
and cause antibiotic adverse effects, nosocomial infections
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tant to recognize BM patients who promptly need antimi-
crobial therapy but also AM patients who do not need
antibiotics and/or hospital stays.
In recent years, it has been proposed that CSF lactate
may be a good marker that can differentiate bacterial
meningitis (> 6 mmol/l), from partially treated meningitis
(4 to 6 mmol/l) and aseptic meningitis (< 2 mmol/l) [10].
However, other researchers have suggested that CSF lac-
tate offers no additional clinically useful information over
conventional CSF markers [11,12]. Other markers, such as
C-reactive protein (CRP) [13] and procalcitonin [14], may
allow differentiation of patients with bacterial meningitis
from those with aseptic meningitis. However, neither of
these markers is routinely used in clinical practice [4]. The
reported diagnostic accuracy of CSF lactate for the differ-
ential diagnosis of BM from AM has varied across studies
[11,12]. To adequately evaluate its accuracy, a systematic
review and meta-analysis were performed on studies that
had investigated the CSF lactate concentration as a differ-
ential marker in both BM and AM patients.
Materials and methods
A protocol was designed before this study was per-
formed as recommended by the Quality of Reporting of
Meta-analyses (QUORUM) statement [15] and the
PRISMA Statement [16].
Search strategy and study selection
Four electronic databases, PubMed [17], Scopus [18],
MEDION database [19] and the Cochrane Library [20],
were searched for suitable studies published before
March 2009. The search terms that were used included
“meningitis AND (lactate OR lactic)”. Only articles writ-
ten in English that evaluated the CSF lactate/lactic acid
concentration for differential diagnosis distinguishing
BM from AM were included.
Clinical diagnosis was used as reference standard for
BM and AM to avoid misclassification of BM patients as
AM. For sub-group analysis, diagnosed BM was defined
as a patient with CSF pleocytosis (CSF leukocyte count >
4 cells/μl) and one of the following criteria: (1) positive
CSF Gram-stained smear for a bacterial pathogen,
(2) positive CSF culture for a bacterial pathogen, (3) posi-
tive CSF latex agglutination assay or polymerase chain
reaction assay for a bacterial pathogen, or (4) positive
blood culture. Diagnosed viral AM was defined as the
diagnosis of a patient with pleocytosis in the CSF of ≥ 4
leukocytes/μl combined with the absence of any of the
four criteria for BM and with either of the following cri-
teria: a positive polymerase chain reaction assay or a
positive culture for viral pathogen or specific antiviral
antibodies in CSF and serum [21].
Studies with fewer than 16 participants were excluded in
order to limit selection bias (≥ 8 BM patients and ≥ 8A M
patients were required for inclusion) [22]. Furthermore,
the following studies were also excluded: (1) animal
studies, case reports, replies and reviews; (2) studies in
which data could not be extracted; and (3) studies that
used lactate as a criteria for diagnosis of AM.
Two independent reviewers (NTH and NTHT)
scanned primary titles and abstracts (when available) to
select potential full text articles for further scrutiny.
When the title and abstract could not be rejected by any
reviewer, the full text of the article was obtained and
carefully reviewed for inclusion by the two reviewers.
Inclusion or exclusion of each study was determined by
discussion and consensus between the two reviewers. If
multiple reports contained overlapping cases, only the
largest report was included. When overlap could not be
determined conclusively, the study with the most inclu-
sive information or the latest report was included.
Data extraction
Two independent investigators (NTH and NTHT)
extracted data from the studies chosen for inclusion.
Disagreements were resolved by discussion and consen-
sus. Studies with criteria for establishing the diagnosis
of BM that relied solely on clinical or laboratory
improvement after antibiotic therapy were excluded. In
selected studies, the following patients who met the fol-
lowing criteria were also excluded from the BM groups:
(1) patients with tuberculous or fungal meningitis,
(2) BM patients who received antibiotics before lumbar
puncture, (3) post-surgery or traumatic patients, and
(4) patients with other central nervous system condi-
tions that could contribute to elevation of CSF lactate
(such as recent stroke, seizures, brain hypoxia, and brain
trauma). A 2 × 2 diagnostic table was constructed from
informative descriptions, lactate values, lactate plots,
sensitivity, specificity, likelihood ratios, and receiver-
operator characteristic (ROC) curves. Other information
for each study, such as author, publication year, age
range of patients, assay methods, stabilizer addition ver-
sus immediate measurement of lactate, prior antibiotic
treatment, tuberculosis, country and city where the
study was performed, study design (cross sectional or
case control), data collection (prospective or retrospec-
tive), assignment of the patient (consecutive or random),
and blinded interpretation of lactate measurements and
diagnostic results, were also recorded.
Quality assessment
The quality of included studies was assessed using cri-
teria suggested by Pai et al. [23], as it has been observed
that these criteria can affect the accuracy of the lactate
Huy et al. Critical Care 2010, 14:R240
http://ccforum.com/content/14/6/R240
Page 2 of 15method. The quality of each study included in the meta-
analysis was determined across five metrics: diagnostic
criteria, study design, exclusion of patients who received
antibiotics before lumbar puncture, exclusion of patients
with other disorders, and the method of the lactate
assay. Since case-control studies reportedly over-
estimate the accuracy result [24], the study design was
scored as follows: studies with cross-sectional were
assigned one point; those with case-control were
assigned zero points. For data collection, prospective
studies were identified and assigned two points, retro-
spective studies were assigned one point, and a study
with unknown study design was assigned zero points. In
addition, studies that recruited consecutive or random
patients were assigned one point, while studies without
this kind of information were assigned zero points. Stu-
dies excluding chronic diseases or other central nervous
disorders patients were assigned one point. Studies that
originally excluded data from subjects who received
antibacterial therapy prior to lumbar puncture were
assigned two points, while studies that included subjects
who received antibacterial therapy prior to lumbar
puncture and excluded in the present report were
assigned one point. Studies that originally excluded data
from subjects with TB meningitis were assigned two
points, while studies that included these subjects and
were excluded by us in this report were assigned one
point. For the quality of the method, studies with
blinded assessment of the lactate assay with diagnostic
results were assigned one point. Since sample processing
is another important issue that may affect the accuracy
of the assay [25], studies using a stabilizer for lactate
sample processing or measuring immediately were
assigned one point. Quality was evaluated by discussion
and consensus after the independent review of each
study by two authors (NTH and NTHT).
Meta-analysis
Data were analyzed using Meta-Disc (version 1.4) software
(Unit of Clinical Biostatistics, Ramón y Cajal Hospital,
Madrid, Spain) [26] unless otherwise stated. The software
is publicly available [27]. Accuracy measures including
sensitivity, specificity, positive likelihood ratio (LR+), nega-
tive likelihood ratio (LR-), and diagnostic odds ratio
(DOR) were computed. The DOR describes the ratio of
the odds of a positive assay in a BM patient compared
with a AM patient and was calculated by LR+/LR- (or
(sensitivity/(1-specificity))/((1-sensitivity)/specificity)) [28].
A DOR > 1 indicated the assay had discriminative power;
a higher DOR indicated more discriminative power.
Heterogeneity of both the sensitivity and specificity
across the studies was tested using a c2 test. A c2
P-value of < 0.05 was considered heterogeneous. An
alternative method to explore the heterogeneity, the I
2
index, was also used. The I
2 index presents the percen-
tage of total variation across studies that is due to het-
erogeneity rather than chance [29]. I
2 values of > 25%,
50%, or 75% were considered to reflect low, moderate,
and high heterogeneity, respectively [29].
Pooling of data was performed if sensitivity and specifi-
city were homogeneous [22]. In the case of heterogeneity,
a Spearman rank correlation coefficient (r)w a sc a l c u -
lated to measure the extent of correlation between sensi-
tivity and specificity. With the Spearman rank correlation
coefficient, if there is a correlation the variation between
studies is mainly due to different cut-off values and
a summary receiver operating characteristic curve may
be modeled [22]. A symmetrical SROC fitting was
performed when the DOR was found to be constant.
A constant DOR is equivalent to the slope of the fitted
regression line at zero (testing whether parameter b =0 )
[26]. As the natural log of DOR (lnDOR) reflects hetero-
geneity, heterogeneity was explored by subgroup analysis
[ 2 2 ] .T h i ss u b g r o u pa n a l y s i sw a sp e r f o r m e du s i n gau n i -
variate meta-regression analysis in order to evaluate the
effect of covariates on diagnostic accuracy (DOR).
A Galbraith plot was constructed to further visually
assess the heterogeneity of lnDOR and to identify outlier
studies [30]. For each study, the ratio of lnDOR/standard
error (SE) of the lnDOR (SE(lnDOR)) was plotted against
1/SE(lnDOR), and was represented by a single dot [22].
If the heterogeneity of lnDOR remained between studies,
the DerSimonian-Laird random effects model (REM) for
fitting SROC was chosen [22], and a P-value < 0.05 was
considered significant. In addition, the heterogeneity of
lnDOR across studies was also examined using multivari-
able logistic meta-regression analysis with the following
covariates as predictor variables: criteria for AM, study
design (prospective or retrospective), patient recruitment
methods (consecutive or random), assay methods, exclu-
sion criteria, prior antibiotic treatment, tuberculous (TB)
meningitis, blinded interpretation of lactate measure-
ment, reliability of the method (stabilizer for lactate sam-
ple or immediate measurement), quality assessment
score, cut-off points, lactate method, age of participants
(child or adult), total number of participants, and effec-
tive sample size (ESS) (where ESS = (4n1*n2)/(n1+n2))
[31]. The variable with the highest P-value was excluded
from the subsequent round of analysis in the multivari-
able meta-regression model in a stepwise downward
manner. A variable was kept in the model if P-value <
0.05. The beta-coefficients and corresponding relative
DOR from the meta-regression analysis revealed the
effect of each variable on the DOR. If a variable was
strongly associated with accuracy, further analysis within
sub-groups (with a minimum of three studies per sub-
group) was conducted to determine diagnostic accuracy
and its SROCs.
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concentration, the Q value and area under the curve
(AUC) were calculated from the SROC curves. The Q
value is the intersection point of the SROC curve with a
diagonal line of the ROC space at which sensitivity
equals specificity; a higher Q value indicates higher
accuracy. AUC values ≥0.5, 0.75, 0.93, or 0.97 were con-
sidered to represent fair, good, very good, or excellent
accuracy [32].
Publication bias
Since publication bias is a concern for meta-analysis, the
potential presence of this bias was identified using a
funnel plot and Egger test [33]. If publication bias was
found, the trim and fill method of Duvall and Tweedie
was performed to add studies that appeared to be miss-
ing [34,35] using the Comprehensive Meta-analysis soft-
ware version 2.0 (Biostat Inc. Englewood, NJ, USA) [36].
The pooled DOR and its 95% confidence interval were
adjusted after the addition of potential missing studies.
Results
Literature search
The literature search initially identified 447 and 600
publications from Pubmed and Scopus, respectively
(Figure 1). After an initial screening of the title and/or
abstract, 115 articles were included for full text reading.
Then additional studies were identified by searching
reference lists and articles that cited relevant publica-
tions using Scopus databases from full text reviews,
review articles, and textbook chapters. These titles and
abstracts were reviewed, and the full text was read if
necessary. A total of 90 articles were excluded from
final analysis due to the following reasons: (1) com-
ment/review/guidelines/reply/case report (n =2 2 ) ,
(2)non-English language (n = 1), (3) no lactate concen-
tration (n =7 ) ,( 4 )n oB Mo rA Mg r o u p( n = 20), (5)
in vitro or animal research (n = 3), (6) unable to exclude
partially treated patients (n = 6), (7) unable to extract
data (n = 11), and (8) low number of participants (n =
20). Finally, 25 studies were selected for final analysis
[11,12,37-58] with agreement between the two reviewers
( = 0.898).
The 25 selected publications, which were performed in
16 countries and on five continents, included 783 BM
and 909 AM patients. The characteristics of these stu-
dies are outlined in Table 1. The average sample size of
the included studies was 31 patients (range, 11 to 86)
for the BM group and 36 patients (range, 9 to 128) for
the AM group. A total of three different methods for
lactate measurement (enzymatic: n = 19, automatic ana-
lyzer: n = 2, gas-liquid chromatography n = 2) were per-
formed in the 25 included studies. One study used both
enzymatic and gas-liquid chromatography methods, with
consistent results between the analysis techniques. In all
of the 25 included studies, the cut-off value of CSF lac-
tate of < 3.5 mmol/L was applied in 12 studies, while
the cut-off value of ≥ 3.5 mmol/L was applied in 12 stu-
dies. One study did not indicate the CSF lactate concen-
tration cut-off value.
Quality of selected studies
In all of the 25 included studies, the lactate assay did
not play a role in the final diagnosis of BM or AM. For
the study design, 18 studies (72%) were cross-sectional,
while seven studies (18%) were case-control studies or
not reported (Table 2). Concerning study design, five
(21%) collected data prospectively, three (13%) collected
data retrospectively, and 16 (69%) did not report the
study design. Twelve (50%) studies used either consecu-
tive or random recruitment of participants, while the
remaining studies (50%) did not state the method of
participant selection. Only one study (4%) described
exclusion criteria for participant enrolment, which
included the exclusion of patients with chronic diseases
or central nervous system disorders. Eleven studies
(46%) did not include data from patients who received
antibacterial therapy prior to lumbar puncture, seven
studies (30%) enrolled subjects who received antibacter-
ial therapy prior to lumbar puncture (these data were
excluded in the present report), and six studies (26%)
did not mention prior antibacterial therapy. Fourteen
studies (58%) originally excluded data from subjects
with tuberculous meningitis; eight studies (35%)
included these subjects and were excluded in the pre-
sent study, while no such information could be found in
two studies (9%). Concerning the quality of the lactate
method, a blinded assessmento ft h el a c t a t ea s s a yw i t h
diagnostic results was reported in only three studies
(13%), while a stabilizer was used for the lactate sample
or an immediate lactate measurement was described in
13 (54%). No study scored the maximal points (11) in
the present analysis, while one study received one point.
The range of total points was one to eight (Table 2).
Meta-analysis
The sensitivity of included studies ranged from 0.86 to
1.00 (mean, 0.96; 95% confidence interval (CI), 0.95 to
0.98) (Figure 2), while the specificity varied widely from
0.43 to 1.00 (mean, 0.94; 95% CI, 0.93 to 0.96). The
mean of LR+ was calculated at 14.53 (95% CI, 8.07 to
26.19), LR- at 0.07 (95% CI, 0.05 to 0.09) and the mean
DOR was 270.0 (95% CI, 142.54 to 519.04).
Heterogeneity was present among the studies with
regard to specificity (c
2 P = 0.000, I
2 = 73.6%), and to LR+
(c
2 P = 0.000, I
2 = 79.5%). Therefore, pooling of data was
not performed [22]. Because of the significant heterogene-
ity of these data, the Spearman rank correlation coefficient
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between sensitivity and specificity. The present results
indicated a poor correlation between sensitivity and speci-
ficity, with a Spearman P = -0.043, suggesting that
variation between studies was not mainly due to different
cut-off values [22]. In contrast, homogeneity was present
among the studies with regard to sensitivity (c
2 P =0 . 1 2 ,
I
2 = 25.9%), LR- (c
2 P = 0.66, I
2 = 0.0%), and for DOR (c
2
P = 0.1009, I
2 = 27.6%). A Galbraith plot was created to
graphically assess the homogenous nature of the lnDOR,
and to identify potential outlier studies (Figure 3). On
the Galbraith plot, 24 studies were inside the 95% bounds
Figure 1 Flow diagram of the study selection process.
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over and below the regression) from the standardized
mean lnDOR, while only one study was the outlier [58].
However, the DOR was just slightly increased from 270.0
to 292.71 after removing the outlier study. further con-
firming the relatively homogenous nature of the lnDOR
[22]. The homogenous nature of the lnDOR across studies
was also examined using meta-regression analysis with the
following covariates as predictor variables: data collection,
study design (prospective or retrospective), recruitment of
the patient (consecutive or random), assay methods, exclu-
sion criteria, prior antibiotic treatment, tuberculous
meningitis, blinded interpretation of lactate measurement,
reliability of the method (lactate sample stabilizer or
immediate measurement), quality assessment score, cut-
off points, lactate method, age of participants (children/
adult), total number of participants, and effective sample
size (ESS). The present results revealed an independent
association of the lnDOR with tested covariates (Data not
shown). These data suggest that the lnDOR of the
included studies is homogenous, and thus a SROC can be
fitted based on the pairs of sensitivity and specificity of the
individual studies [22].
The slope of the fitted regression line of the Moses-
Shapiro-Littenberg model was zero (testing whether
parameter b =0 ,P = 0.84), indicating a constant DOR.
Therefore, a symmetrical SROC fitting was performed
( F i g u r e4 ) .T h ep r e s e n tr e s u l t ss h o w e dt h a tt h eS R O C
curve was positioned near the upper left corner of the
SROC curve, with the Q value and AUC at 0.9451 and
0.9840, respectively, indicating excellent accuracy.
Sub meta-analysis of lactate as a differential marker for
diagnosed BM from AM
Meta-analysis was further performed to assess the diag-
nostic accuracy of lactate between diagnosed BM and
AM. Nineteen studies [11,12,38,39,41-43,46-56,59] that
analyzed only diagnosed BM and five other studies
[37,40,44,45,57] that included diagnosed BM as well as
clinical BM that could be extracted separately were
included in the subgroup analysis. The specificity and
LR+ were heterogeneous among the studies, but
Table 1 Summary of included studies
Study (ref) Year Country Number of patients Age Lactate method Cut-off (mmol/L) Test results
BM AM TP
a FP FN TN
Abro [37] 2008 UAE 86 48 Adult Enz
d 3.8 85 0 1 48
Kleine [59] 2003 Germany 73 128 Adult Enz 2.61 73 0 0 128
Schwarz [58] 2000 Germany 16 14 Adult NR
c 2.1 15 8 1 6
Uduman [57] 2000 UAE 23 42 Children Enz NR 22 3 1 39
Cameron [38] 1993 UK 11 9 Children Enz 4.1 11 0 0 9
Genton [39] 1990 Switzerland 19 28 Adult Auto
e 4.2 18 0 1 28
Shaltout [40] 1989 Kuwait 14 9 Children Auto 3 13 0 1 9
Donald [41] 1986 S. Africa 43 23 Children Enz 2.85 40 0 3 23
Nelson [42] 1986 Sweden 11 28 Children Enz 2.4 11 3 0 25
Low [43] 1986 Singapore 22 54 Children Enz 2.78 19 8 3 46
Ruuskanen [12] 1985 Finland 32 30 Children Enz 3 30 2 2 28
Lester [44] 1985 Denmark 15 15 Child/adult Enz 4.3 15 0 0 15
Vanprapar [45] 1983 Thailand 22 18 Children Enz 3.89 20 0 2 18
Mandal [46] 1983 UK 20 59 Children Enz 3.9 20 5 0 54
Pönkä [47] 1983 Finland 11 27 Child/adult Enz 3 10 1 1 26
Briem [48] 1983 Sweden 45 102 Child/adult Enz 3.5 45 4 0 98
Berg [49] 1982 Sweden 18 121 Child/adult Enz 3 16 9 2 112
Eross [50] 1981 Australia 66 31 Child/adult Enz 3.9 64 0 2 31
Knight [51] 1981 US 68 20 Children Enz 3.3 68 3 0 17
Curtis [52] 1981 UK 13 12 Child/adult Enz 2.8 13 0 0 12
Lannigan [53] 1980 Canada 14 14 Adult Enz 3.89 13 3 1 11
Gästrin [11] 1979 Sweden 38 17 Child/adult GL
b 3.5 37 3 1 14
Lauwers [54] 1978 Belgium 35 20 NR
c GL 3.89 33 0 2 20
Controni [55] 1977 US 55 15 Children Enz&GL 2.78 53 0 2 15
Bland [56] 1974 US 13 25 Children Enz 4.44 12 0 1 25
aTP, true-positive; FP, false-positive; FN, false-negative; TN, true-negative;
bGL, gas-liquid chromatography;
cNR, not reported;
dEnz, Enzymatic;
eAutomatic analyzer.
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nous (data not shown). Symmetrical SROC fitting was
also performed for these five studies due to a constant
DOR (testing whether parameter b =0 ,P = 0.4452).
The result showed a SROC curve with the Q value and
AUC at 0.9426 and 0.9828, respectively, indicating
excellent accuracy, and was consistent with the 25
included studies (data not shown).
Sub meta-analysis of lactate as a differential marker for
diagnosed BM from diagnosed viral AM
Meta-analysis was further performed to assess the diag-
nostic accuracy of lactate between diagnosed BM and
diagnosed viral AM. One study that recruited only diag-
n o s e dv i r a lA Ma n df o u ro t h e rs t u d i e st h a ti n c l u d e d
diagnosed viral AM as well as clinical AM that could be
extracted separately were included in the subgroup ana-
lysis. The specificity was still heterogeneous among the
studies (c
2 P =0 . 1 4 ,I
2 = 42.1%) of diagnostic accuracy,
b u ts e n s i t i v i t y ,L R + ,L R - ,a n dD O Rw e r es i g n i f i c a n t l y
homogenous (data not shown). Symmetrical SROC fit-
ting was also performed for these five studies due to
a constant DOR (testing whether parameter b =0 ,
P = 0.9145). The result revealed a SROC curve with the
Q value and AUC at 0.9563 and 0.9891, respectively,
suggesting excellent accuracy, and was consistent with
above results (data not shown).
Head-to-head comparison of CSF lactate level versus
conventional markers
In order to compare the diagnostic accuracy of the CSF
lactate concentration and other conventional markers
f o rd i a g n o s i so fB M ,d a t aw e r ee x t r a c t e df r o mt h e2 5
selected articles only if the study had on the same set of
specimens a parallel analysis of CSF lactate and a con-
ventional marker. Since conventional markers were used
as the diagnostic criteria of BM, only BM patients with
confirmed diagnosis were extracted in this analysis. The
extracted data are shown in Table 3, which includes the
DOR values for CSF lactate, CSF glucose, CSF/plasma
glucose quotient, CSF protein, CSF total number leuko-
cytes, CSF percentages of granulocytes, and CSF number
of granulocytes.
In the present study, for diagnosis of BM, five studies
performed head to head comparisons of CSF lactate ver-
sus CSF glucose, four versus the CSF/plasma glucose
Table 2 Quality of included studies
Study (ref) Design
a Data collection
b Recruit
c Exclusion
d Prior treatment
e TB
f Blinded
g Reliability
h Total score
Abro [37] 0 0 0 1 2 2 0 0 5
Kleine [59] 1 1 0 0 2 2 0 0 6
Schwarz [58] 1 2 1 0 2 0 0 0 6
Uduman [57] 1 2 1 0 2 2 0 0 8
Cameron [38] 0 0 0 0 2 1 0 1 4
Genton [39] 1 1 1 0 1 1 1 1 7
Shaltout [40] 1 0 1 0 1 1 1 0 5
Donald [41] 0 0 0 0 0 1 0 1 2
Nelson [42] 1 1 1 0 1 2 1 1 8
Low [43] 0 0 0 0 1 2 0 0 3
Ruuskanen [12] 1 0 0 0 0 0 0 0 1
Lester [44] 1 2 1 0 1 2 0 1 8
Vanprapar [45] 1 0 0 0 0 0 0 0 1
Mandal [46] 1 0 1 0 1 2 0 1 6
Pönkä [47] 1 0 1 0 0 2 0 0 4
Briem [48] 0 2 0 0 2 1 0 0 5
Berg [49] 1 2 1 0 2 1 0 1 8
Eross [50] 1 2 0 0 2 2 0 1 8
Knight [51] 0 0 0 0 0 2 0 1 3
Curtis [52] 1 0 1 0 2 1 0 1 6
Lannigan [53] 1 0 1 0 2 2 0 0 6
Gästrin [11] 1 0 0 0 0 2 0 1 4
Lauwers [54] 1 0 1 0 2 1 0 0 5
Controni [55] 1 0 1 0 1 1 0 1 5
Bland [56] 0 0 0 0 2 2 0 1 5
aStudy design (cross-sectional or case-control);
bData collection (prospective or retrospective);
crecruitment of the patient (consecutive or random);
dexclusion
criteria;
eprior antibiotic treatment;
ftuberculous meningitis;
gblinded interpretation of lactate measurement;
hreliability of the method (stabilizer for lactate
sample or immediate measurement).
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number of leukocytes, one versus percentages of granulo-
cytes, and one versus CSF number of granulocytes. How-
ever, TB meningitis patients and partially treated BM
patients could not be excluded from the conventional
markers assays. Therefore, in a secondary meta-analysis
these patients were included in the BM group. Higher
DOR values were observed with the CSF lactate level
than with the conventional markers in all studies except
f o ro n es t u d yf o rt h eC S Fp r o t e i na s s a y[ 4 0 ]a n do n e
A B
C D
E
Figure 2 Diagnostic accuracy of the CSF lactate concentration for differential diagnosis of BM from AM. Forest plot showing sensitivity,
specificity, LR+, LR-, and DOR with 95% confidence intervals (95% CI) for the lactate concentration for differential diagnosis of BM from AM. The
size of the circle represents the study size.
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values of the CSF lactate concentration, CSF glucose
level, CSF/plasma glucose quotient, and CSF total num-
ber of leukocytes were found to be constant (data not
shown), symmetrical SROC fitting by a random effects
model was performed for these assays. On the other
hand, asymmetrical SROC fitting by a random effects
model was computed for the CSF protein assay because
the slope of the fitted regression line of the Moses-Sha-
piro-Littenberg model was not zero (data not shown).
Following SROC analysis for all four subgroups of the
CSF lactate concentration (Figure 5), the overall AUC
was 0.977 to 0.988, which was consistent with the
primary analysis of the 25 included studies. In addition,
the AUC values were found to be lower for the four con-
ventional markers (0.881, 0.952, 0.862, and 0.948 for CSF
glucose, CSF/plasma glucose quotient, CSF protein, and
CSF total number of leukocytes, respectively), suggesting
a lower accuracy compared to the CSF lactate test.
Assessment of publication bias
The relatively asymmetric funnel plot (Figure 6) and the
Egger intercept (2.95, two-tailed P = 0.00004) suggested
the presence of a publication bias. Using the trim and
fill method of Duvall and Tweedie, 11 missing studies
were required in the left side of the funnel plot in order
l
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/
 
S
E
(
l
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D
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)
1 / SE(lnDOR)
Figure 3 Galbraith plot of the CSF lactate concentration for differential diagnosis of BM from AM. The horizontal axis represents lnDOR/
SE(lnDOR), while the vertical axis represents 1/SE(lnDOR). The regression runs through the origin interval (central solid line). The 95% confidence
interval is between the two outer parallel lines at two units above and below the regression line.
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Page 9 of 15to make the plot symmetric. However, the pooled
lnDOR dropped just slightly from 5.60 (95% CI, 4.95 to
.25) to 4.84 (95% CI, 4.16 to 5.53) after addition of these
missing studies.
Discussion
The present meta-analysis revealed that the AUC of CSF
lactate concentration was 0.9840 (Figure 4), indicating
an excellent level of overall accuracy. The overall perfor-
mance was highest for the CSF lactate concentration
compared to the performances of the four conventional
m a r k e r s( C S Fg l u c o s e ,C S F / p lasma glucose quotient,
CSF protein, and CSF total number of leukocytes) based
on head-to-head meta-analytic SROC curves and their
AUC (Figure 5), which was in good agreement with pre-
vious literature [4,59]. CSF lactate is less useful if it has
a low concentration, but the assay is supportive if it is
positive, especially if the diagnosis was otherwise not
conclusive. In such cases, increased CSF lactate should
be considered a sign of BM. Because of the lactate assay,
several BM patients with elevated CSF lactate and mini-
mal CSF abnormalities have been treated with antibio-
tics prior to culture test results [11,47,55]. Moreover, an
increased CSF lactate level has been also proposed as a
good indicator of CSF infection in intra-ventricular
hemorrhagic patients with an external ventricular drain
[60,61]. However, clinicians should be aware that CSF
lactate is also increased in several central nervous sys-
tem diseases such stroke (2 to 8 mmol/l) [62,63], con-
vulsion (2 to 4 mmol/l) [64], cerebral trauma (2 to
9 mmol/l) [52], hypoglycemic coma (2 to 6 mmol/l) [65].
T h em e a s u r e m e n to fC S Fl a c t a t ec o n c e n t r a t i o ni sa
simple, rapid, inexpensive assay, takes just 15 minutes,
and can be performed at the bedside. In addition, the
CSF lactate concentration is useful during the course of
treatment, because a rapid CSF lactate decrease is indi-
cative of good prognosis [39]. Since the CSF lactate con-
centration is not specific for BM, the results of this
Figure 4 SROC curve of the CSF lactate concentration for differential diagnosis of BM from AM. Each circle indicates an individual study
in the meta-analysis (n = 25). The curve is the regression that summarizes the overall diagnostic accuracy. SE(AUC), standard error of AUC; SE
(Q*), standard error of the Q* value. The size of the circle represents the study size.
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Page 10 of 15assay should be interpreted in parallel with clinical find-
ings and the results of conventional assays including
CSF concentrations of protein, cells, glucose, and a
microbiological examination of CSF. The cut-off value
for CSF lactate concentration ranges from 2.1 to
4.44 mmol/L, suggesting a variance between instrument,
hospital labs, and the method. Therefore, every center
should set its own cut-off value for CSF lactate concen-
tration. Another disadvantage of CSF lactate is that it is
not useful in the choice of antibiotic selection, which
must be based on the results of microscopic examina-
tion of a smear or culture for bacteria, as well as the
other clinical data.
The mechanism of the increased concentration of lac-
tate in the CSF of patients with BM is not clear, but it
has been linked with anaerobic glycolysis of brain tissue
due to a decrease cerebral blood flow and oxygen
uptake [66,67]. Additionally, the concentration of CSF
lactate is independent of serum lactate, probably due to
its ionized state that crosses the blood-CSF barrier at a
very slow rate [68], suggesting another advantage over
CSF glucose assay [38].
The present systemic review has several strengths.
First, the criteria and protocol were defined, the
protocol was followed, and a search of several databases
and sources was performed to identify potential studies.
The quality of included studies was assessed by using
several criteria that could affect diagnostic accuracy.
These steps were carried out by two independent
researchers. Heterogeneity was explored in accordance
with published guidelines. Then, the summary ROC
curve was computed and Q values and AUC were calcu-
lated in order to evaluate the diagnostic accuracy of CSF
lactate marker. Potential effects of several covariates on
the diagnostic accuracy were assessed, but none were
found.
Because publication bias can affect the accuracy of
diagnostic assays, potential publication bias was assessed
using funnel plots. The results showed a skewed funnel
shape, suggesting a potential publication bias in the lit-
erature (Figure 6). However, it was noted that the three
largest studies [37,48,50] had higher DORs compared to
smaller studies, and they had similar almost perfect
accuracy [38,44,56]. This discrepancy could be explained
by the calculation method of adding 0.5 to cells with
zero, suggesting a weakness of the funnel plot when the
assay investigated has excellent accuracy. Another main
concern is the lack of some additional databases that
Table 3 Head-to-head comparison of CSF lactate concentration and other conventional markers
Study (ref) Conventional markers (location) Conventional markers assay results Lactate assay results
TP FP FN TN DOR TP FP FN TN DOR
Shaltout
a,b,c [40] Glucose (CSF) 10 1 6 41 68.3 14 1 2 41 287.0
Donald
a,c [41] 33 2 15 67 73.7 45 3 3 69 345.0
Pönkä [47] 5 0 5 27 55.0 10 1 1 26 260.0
Briem
a,c [48] 30 0 23 193 502.3 47 4 0 167 3,536.1
Lannigan [53] 11 4 2 10 13.8 13 3 1 11 47.7
Genton
a,b [39] Glucose quotient (CSF/plasma) 21 0 2 27 473.0 24 0 1 28 931.0
Nelson
b [42] 10 0 7 26 74.2 18 3 0 25 269.6
Briem
a,c [48] 40 1 13 191 587.7 47 4 0 167 3,536.1
Berg
a [49] 16 10 2 78 62.4 16 9 2 112 99.6
Genton
a,b [39] Protein concentration (CSF) 18 0 3 25 269.6 24 0 1 28 931.0
Shaltout
a,b,c [40] 13 0 3 42 327.9 14 1 2 41 287.0
Donald
a,c [41] 39 1 9 68 294.7 45 3 3 69 345.0
Vanprapar [45] 8 0 3 12 60.7 12 0 1 18 308.3
Pönkä [47] 10 11 1 16 14.5 10 1 1 26 260.0
Briem
a,c [48] 41 7 9 184 119.8 47 4 0 167 3,536.1
Berg
a [49] 11 14 4 88 17.3 16 9 2 112 99.6
Genton
a,b [39] Leukocytes (CSF total number) 16 0 8 26 102.9 24 0 1 28 931.0
Shaltout
a,b,c [40] 10 2 6 39 32.5 14 1 2 41 287.0
Nelson
b [42] 17 1 1 26 442.0 18 3 0 25 269.6
Pönkä [47] 7 2 4 25 21.9 10 1 1 26 260.0
Lannigan [53] 12 2 2 12 36.0 13 3 1 11 47.7
Genton
a,b [39] Granulocytes (CSF %) 20 7 4 19 13.6 24 0 1 28 931.0
Pönkä [47] Neutrophils (CSF number) 7 6 4 21 6.1 10 1 1 26 260.0
aIncluded TB meningitis;
bincluded prior treated patients; included normal patients in the AM group. TP, true-positive; FP, false-positive; FN, false-negative;
TN, true-negative; DOR, diagnostic odds ratio.
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Figure 5 SROC curve of the head to head comparison of the CSF lactate concentration and other conventional markers.E a c hc i r c l e
indicates an individual study in the meta-analysis. The curve is the regression that summarizes the overall diagnostic accuracy. SE(AUC), standard
error of AUC; SE(Q*), standard error of Q* value. The size of the circle represents the study size.
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Page 12 of 15were used for searching, that is, we did not access
EMBASE, which could have added more relevant stu-
d i e s .w ed i ds e a r c hS c o p u s ,w h i c hi sr e p o r t e d l y9 1 . 6 %
overlapped with EMBASE [69]. Therefore, we think that
we have not missed many studies large enough to
change the overall impression of our results.
In addition, non-English language studies were also
excluded; the non-English language reports represented
approximately 10% of all initial articles. We excluded
non-English articles in meta-analyses due to limited
resource and potential error in the translation and inter-
pretation in several languages including Chinese, Croa-
tian, Dutch, French, German, Hebrew, Italian, Korean,
Norwegian, Polish, Portuguese, Romanian, Russian,
Serbian, Spanish, and Turkish. The odds ratio in meta-
analyses from non-English articles is reportedly 0.8 (95%
CI, 0.7 to 1.0) times lower than that from English-
written publications [70], therefore, it is unlikely that
the inclusion of these non-English articles would have
altered our main conclusions substantially.
In addition, studies that reported non-significant
results are less likely to be accepted for publication. All
of these potentially missing data could result in a signifi-
cant publication bias. However, the trim and fill method
of Duvall and Tweedie was used to overcome this bias,
and it was found that it was unlikely to distort the over-
all diagnostic performance of the lactate concentration
(Figure 6).
lnDOR
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Figure 6 Funnel plots for evaluation of publication bias in the 25 included studies. The funnel graph plots the standard error of the
lnDOR (SE(lnDOR)) against the log of the diagnostic odds ratio (lnDOR). Each empty circle represents one observed study in the meta-analysis,
while an empty diamond indicates the original pooled lnDOR and its 95% confidence interval. The Trim and Fill method was used to find
unpublished studies (filled circles) and compute the true vertical line center of the funnel and the adjusted pooled lnDOR (filled diamond) after
adding in missing studies (depicted with black dots).
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The present meta-analysis study indicated that for dis-
crimination of BM from AM, the CSF lactate concentra-
tion is a good single indicator and a better marker
compared to other conventional markers including CSF
glucose, CSF/plasma glucose quotient, CSF protein, and
CSF total number of leukocytes. Cost-effectiveness stu-
dies should be performed to investigate the economic
impact of using this technique as a routine assay in hos-
pital to distinguish BM from AM.
Key messages
￿ The diagnostic accuracy of cerebrospinal fluid (CSF)
lactate assay for differential diagnosis between bacterial
meningitis and aseptic meningitis was excellent with Q
value of 0.9451 and area under the curve of 0.9840.
￿ CSF lactate was a better marker for distinguishing
bacterial meningitis from aseptic meningitis compared
to other conventional markers including CSF glucose,
CSF/plasma glucose quotient, CSF protein, and CSF
total number of leukocytes
Abbreviations
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